EPGL - The EP Foundation for Education Inc., a 501 (C)3 Not-for-Profit Corporation, Announces the Development and Implementation of Six Live Online CME-Accredited Educational Seminars in Cooperation with EP Global Communications, Inc and Vemics, Inc.
Monday February 5, 8:30 am ET
The Working Title is 'Current Treatment Therapies for the Management of Spasticity in People with Movement Disorders'
The Six Part Program series is made possible in part by an Unrestricted Educational Grant from Allergan, Inc.
JOHNSTOWN, Pa., Feb. 5 /PRNewswire-FirstCall/ - EP Global Communications Inc. (OTC Bulletin Board: EPGL - News) and its program sponsor, EP Foundation for Education, Inc. (EPFE) -- a 501 ©3 not-for-profit corporation -- announced today the receipt of an unrestricted educational grant from Allergan, Inc. to develop six online live interactive CME accredited educational programs. The working title of the program series is "Current Treatment Therapies for Spasticity in People with Movement Disorders." The series will utilize Vemics Inc.'s proprietary system that produces live, interactive, TV-quality programs online and is offered under the EP LiveOnline educational brand, a joint venture between EPGL and Vemics, Inc.
ADVERTISEMENT
Faculty will be chosen by the American Academy of Developmental Medicine & Dentistry, with CME accreditation Provided by the University of Tennessee College of Medicine -- Chattanooga Unit. The target audience and expected attendees include: primary care physicians, pediatric and adult neurologists, psychiatrists, occupational and physical therapists, developmental disability nurses, physical medicine and rehabilitation specialists. Also expected among the primary audience are families, caregivers, and other allied healthcare providers involved in the treatment, care and development of people with chronic long term special needs such as cerebral palsy, spasticity, dystonia, and traumatic brain injury, and other complex movement disorders. The programs will take place once a month, beginning in May of 2007. Specific dates for these programs will be forthcoming and announced on the company's web site at www.eparent.com along with appropriate announcements in various media.
The goal of the program is to provide exceptional educational opportunities for physicians and allied healthcare professionals, as well as families and caregivers, specifically expanding their awareness of advances in the diagnosis and treatment of the aforementioned conditions. The conference will also be made accessible to families of children and adults who have movement disorders, to promote and encourage a better understanding of the diagnosis, treatment and care. Each program will be offered to various U.S. Army bases and medical facilities as well as the EFMP Program under the company's contract with the U.S. Army.
About the EP Foundation for Education
The Atlanta-based EP Foundation for Education, Inc. is a 501©3 Not for Profit Corporation headed by Frank J. Murphy. The organization is dedicated to improving the lives of people with disabilities, special health care needs and chronic conditions, and the families and others involved in their care and development.
About EP Global Communications, Inc.
EP Global Communications ("Exceptional Parent") is a 36-year-old award- winning publishing and communications company that provides practical advice and emotional support to families of children and adults with disabilities and special health care needs -- as well as the physicians, allied health care and educational professionals who are involved in their care and development. EP uses a multi-media approach to disseminate information via: its monthly award- winning publication, Exceptional Parent; Web site (www.eparent.com); clinical custom communications projects; the EP Library Bookstore (www.eplibrary.com) of disability books, videos and tapes; on-line, interactive CME/CEU accredited seminars & teleconferences on a wide range of special needs topics.
About Vemics, Inc.
Vemics, Inc. (VMCI:PK) is a leading provider of hosted, real-time collaboration and learning applications. Vemics LiveAccess(TM) solutions combine multipoint video/voice and data technologies with industry specific content, consulting expertise and deep customer support enabling organizations large and small to work, collaborate and learn face-to-face, online from almost anywhere with little or no capital investment. Vemics NuScribe(TM) provides voice-activated solutions for physician transcription and electronic medical record creation. Vemics is based in New York with offices in Boston, Philadelphia and Austin. www.vemics.com.
About the American Academy of Developmental Medicine and Dentistry
The mission of the American Academy of Developmental Medicine and Dentistry (AADMD) is to improve the overall health of individuals with Neurodevelopmental Disorders and/or Intellectual Disabilities (ND/ID).
About Allergan, Inc.
Allergan, Inc., with headquarters in Irvine, California, is a global specialty pharmaceutical company that develops and commercializes innovative products for the eye care, neuromodulator, skin care and other specialty markets. In addition to its discovery-to-development research programs, Allergan has global marketing and sales capabilities in over 100 countries that deliver value to our customers, satisfy unmet medical needs and improve people's lives. Driven by technology and innovation, Allergan addresses the needs of consumers across the world with over 5,000 employees worldwide, 4 world-class Research and Development facilities and 3 state-of-the-art manufacturing plants.
Safe Harbor Statement
Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward- looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
--------------------------------------------------------------------------------
Source: EP Global Communications
News 
Market Data 
Discover 
